MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
September 21, 2005
Stephen D. Simpson
Can Biomet Stay Limber? Concerns about pricing have buffeted the orthopedic space and the No. 4 player in hips and knees. Whatever the case turns out to be, Biomet is probably a bit riskier than average. mark for My Articles similar articles
The Motley Fool
January 31, 2006
Stephen D. Simpson
Zimmer Muddles Through So long as the pressures in the orthopedic sector prove less than originally feared, investors could still make money here. mark for My Articles similar articles
The Motley Fool
March 22, 2005
Stephen D. Simpson
Can Biomet Elbow the Competition? The No. 4 player in orthopedics looks to close the gap. No matter what valuation metric you want to look at, Biomet shares look expensive on an absolute basis. mark for My Articles similar articles
The Motley Fool
October 27, 2005
Stephen D. Simpson
Will Smith & Nephew Keep Flexing? This smaller, British, orthopedic company has competitive products, but industry trends could hurt it. However, the entire orthopedic sector is getting pretty interesting from a value perspective. mark for My Articles similar articles
The Motley Fool
July 20, 2005
Stephen D. Simpson
Stryker Delivers the Growth Med-tech company Stryker has been a consistent grower for years and shows no signs of slowing down. There will be bumps along the way, but Stryker is an interesting large-cap growth play. mark for My Articles similar articles
The Motley Fool
December 21, 2005
Stephen D. Simpson
Biomet Takes a Bum Knee Company excuses aside, a subpar quarter lends credence to the notion that orthopedics companies are still in a tough spot. Investors, take note. mark for My Articles similar articles
The Motley Fool
July 27, 2006
Stephen D. Simpson
Zimmer Provides Quarterly Information, and More In addition to its quarterly review, the orthopedic company gave some insight into the government probe. Investors, take note. mark for My Articles similar articles
The Motley Fool
June 30, 2005
Stephen D. Simpson
Biomet Wants Your Body Steady growth continues at the #4 orthopedics player. But Biomet shares haven't had a great year so far, hovering close to their 52-week low. mark for My Articles similar articles
The Motley Fool
April 13, 2006
Stephen D. Simpson
A Foolish Baby Shower: Stryker Here is a stock you can be comfortable with buying for your little one with the intention that it would be held for at least 18 years. mark for My Articles similar articles
The Motley Fool
April 27, 2006
Stephen D. Simpson
Guidance Brings Zimmer to Its Knees Sales were a little light this quarter, and the company will have to hustle to meet full-year projections. Investors, tread carefully and only buy when there is a fitting margin of safety here. mark for My Articles similar articles
The Motley Fool
July 21, 2006
Stephen D. Simpson
Stryker and the Terror of the Unknown This has been a pretty bad year to be a good medical technology company. Fears about future pricing and the DOJ investigation keep a lid on the entire sector. So, what about that future for Stryker? Investors, take note. mark for My Articles similar articles
The Motley Fool
April 28, 2004
Glen Trematore
Zimmer Makes a Family Proud Zimmer Holdings looks strong when compared with other orthopedic/medical device makers. mark for My Articles similar articles
The Motley Fool
February 9, 2006
Stephen D. Simpson
Growth Not Enough for Smith & Nephew This orthopedic company has market-leading growth, but just not enough cash flow. Investors shouldn't get too excited about these shares. mark for My Articles similar articles
The Motley Fool
April 29, 2011
David Williamson
Johnson & Johnson's Traumatic Purchase Johnson & Johnson agrees to purchase trauma and spine specialist Synthes. mark for My Articles similar articles
The Motley Fool
October 19, 2005
Stephen D. Simpson
Stryker Still on Target The ever-present 20% growth target will get tougher to hit, but this is a quality medical company. Investors, take note. mark for My Articles similar articles
The Motley Fool
July 23, 2010
Jordan DiPietro
Better Health Care Buy: Stryker or Zimmer Holdings? Which stock is a better purchase to consider? mark for My Articles similar articles
The Motley Fool
March 31, 2005
Stephen D. Simpson
The DOJ Goes Fishing for Orthopedics The government's industry-wide investigation of orthopedics is more of a buying opportunity than a real threat. mark for My Articles similar articles
The Motley Fool
January 29, 2007
Matthew Crews
Only One Bone to Pick With Stryker With products for wherever you hurt, the med-tech company continues to deliver solid earnings. mark for My Articles similar articles
The Motley Fool
May 2, 2011
Anupama Pattanaik
J&J Attempts to Create Major "Synthes"-is Johnson & Johnson will acquire the medical device maker for $21.3 billion. mark for My Articles similar articles
The Motley Fool
October 18, 2006
Matthew Crews
Stryker Is Steady Eddy How long can Stryker maintain its Steady Eddy persona? Net earnings will decelerate when gross margins peak. mark for My Articles similar articles
The Motley Fool
July 23, 2009
Robert Steyer
Long Convalescence for Device Makers Orthopedic product specialists Stryker and Zimmer Holdings forecast a slow-motion recovery. mark for My Articles similar articles
The Motley Fool
July 27, 2006
Stephen D. Simpson
Smith & Nephew: Better Is Good Enough For British medical device company Smith & Nephew investors, better-than-expected is just fine. mark for My Articles similar articles
The Motley Fool
July 28, 2005
Stephen D. Simpson
Zimmer at a Simmer Strong demand for reconstructive products keeps this orthopedics company limber. Zimmer's 30-plus trailing price-to-earnings ratio still looks high, but it is in line with this industry's current multiples. mark for My Articles similar articles
The Motley Fool
April 21, 2006
Stephen D. Simpson
Stryker Strikes a Chord A solid quarter and generally positive guidance refuels investor enthusiasm. mark for My Articles similar articles
The Motley Fool
March 21, 2006
Stephen D. Simpson
Biomet's Stiff Joints Pricing isn't collapsing, but the orthopedics company isn't exactly prospering, either. Investors, beware. mark for My Articles similar articles
The Motley Fool
May 20, 2011
Andrea Kalvesmaki
Johnson & Johnson's Billion-Dollar Move Orthopedics are the name of the game for this company's future earnings. mark for My Articles similar articles
The Motley Fool
September 14, 2005
Stephen D. Simpson
Orthopedic Sector Stumbles Already antsy about potential pricing, investors reacted badly to British orthopedic company Smith & Nephew's earnings guidance. mark for My Articles similar articles
The Motley Fool
April 26, 2005
Stephen D. Simpson
Growth Is Knee-High Zimmer turns in another fine quarter, with strength in knee implants leading the way. mark for My Articles similar articles
The Motley Fool
July 18, 2006
Stephen D. Simpson
Can J&J Do Better Than GDP? Investors and analysts are obsessed with growth, but Johnson & Johnson isn't. mark for My Articles similar articles
The Motley Fool
February 1, 2005
Stephen D. Simpson
Zimmer Shoots From the Hip Pure-play orthopedic company delivers the goods, but at what cost? Zimmer carries a price tag that would make a value investor's bones ache. mark for My Articles similar articles
BusinessWeek
December 3, 2007
Arlene Weintraub
Is the Hip Bone Connected To a Fee? An investigation alleges some orthopedics makers have showered surgeons with fees and perks. mark for My Articles similar articles
The Motley Fool
August 28, 2008
Brian Orelli
Stryker Strikes Back The orthopedics maker sues to stop a costly federal investigation. mark for My Articles similar articles
The Motley Fool
October 17, 2008
Brian Orelli
Shareholders Slap Stryker A little earnings miss sends the medical technology company down more than necessary. mark for My Articles similar articles
The Motley Fool
October 5, 2005
Stephen D. Simpson
Wright Goes Wrong A weak third quarter compounds troubles for this pipeline-challenged orthopedics player. There is no compelling reason to purchase this stock today. mark for My Articles similar articles
The Motley Fool
October 18, 2007
Billy Fisher
An Empire Strykes Back Stryker reports a quarter of double-digit growth in revenue and earnings. Investors, take note. mark for My Articles similar articles
The Motley Fool
March 23, 2004
Glen Trematore
Stryker's a Warrior Need a new hip or a new addition to your portfolio? Consider Stryker. mark for My Articles similar articles
The Motley Fool
March 28, 2006
Stephen D. Simpson
A Surprising Turn at Biomet The large orthopedic company replaces one of its founders. This change doesn't really make the stock dramatically more, or less, attractive than before. Investors, take note. mark for My Articles similar articles
BusinessWeek
December 6, 2004
Kathleen Kerwin
Knees And Hips -- And Now What? Stryker may need more than artificial joints. Its CEO-to-be is betting on biotech. mark for My Articles similar articles
The Motley Fool
July 20, 2007
Ryan Fuhrmann
Stryker Does a Body Good The orthopedics company continues its double-digit growth in an industry with a bright future. Investors, take note. mark for My Articles similar articles
BusinessWeek
May 30, 2005
Michael Arndt
BW 50: A Test Of Zimmer's Agility Artificial joint maker Zimmer Holdings Inc. has the lead in a hot business. But the company faces a Justice probe and price pressures. mark for My Articles similar articles
The Motley Fool
July 26, 2007
Ryan Fuhrmann
Zimmer Simmers The maker of hip and knee replacements gets a leg up on the market. Investors, take note. mark for My Articles similar articles
The Motley Fool
July 18, 2008
Brian Orelli
What Strikes Against Stryker? High growth isn't enough to impress investors. mark for My Articles similar articles
The Motley Fool
June 28, 2006
Stephen D. Simpson
Feds Once Again Knocking on Ortho Doors A second round of subpoenas rattles the medical device sector. mark for My Articles similar articles
BusinessWeek
November 12, 2007
Arlene Weintraub
Getting Hip to the Boomers Stryker's new orthopedic technology gives aging patients an alternative to full joint replacement. mark for My Articles similar articles
The Motley Fool
September 27, 2005
Stephen D. Simpson
Not Bracing for the Worst Price competition and tighter reimbursement? dj Orthopedics isn't worrying about them. Investors may not rush to sell, but they should perhaps start thinking about a protective stop-loss to lock on some easy profits. mark for My Articles similar articles
The Motley Fool
September 17, 2010
James Early
Today's Buy Opportunity: Johnson & Johnson The case for Johnson & Johnson is very simple: Here's a company that's been around forever, that pays a 3.5% dividend, and that's spread across arguably the most necessary sector (behind water and sewage): health care. mark for My Articles similar articles
The Motley Fool
January 30, 2007
Ryan Fuhrmann
Zimmer Implants a New High Investors, the orthopedic designer, developer, and manufacturer isn't cheap, but stellar companies rarely are. mark for My Articles similar articles
The Motley Fool
September 20, 2006
Ryan Fuhrmann
Biomet's Aching Joints Biomet operates in the appealing medical device industry, but current growth trends are giving investors a headache. mark for My Articles similar articles
The Motley Fool
January 10, 2005
W.D. Crotty
This "dj" is Primed to Play Hits Medical device company dj Orthopedics reaps huge gains after a good sales report. mark for My Articles similar articles
BusinessWeek
October 3, 2005
Gene G. Marcial
Giant Strides At Symmetry Symmetry Medical is sitting pretty in the fast-growing orthopedics market. mark for My Articles similar articles